BioSpace News Archive

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Inc. is pleased to announce that it has received a notice of allowance from the Japanese Patent Office for patent application No. 2021-547495 entitled: Compositions and Methods for Treating Idiopathic Pulmonary Fibrosis (IPF).

January 11, 2024
·
4 min read
Business

Identifai-Genetics Launches Its First U.S. Clinical Trial, Led by Professor Ronald Wapner

Identifai-Genetics , developer of unique AI-based solutions for non-invasive fetal DNA sequencing, announced today that it has launched its first US clinical trial, in collaboration with Columbia University and the Columbia University Irving Medical Center in New York.

January 11, 2024
·
2 min read
Business

Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

Insulet Corporation today announced plans to release its financial results for the fourth quarter and full year of 2023 on February 22, 2024 after the close of the financial markets.

January 11, 2024
·
1 min read
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial (RCT).

January 11, 2024
·
8 min read
Business

SmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEO

SmartLabs, Inc. today announced that Brian Taylor has been appointed interim Chief Executive Officer effective January 5th.

January 11, 2024
·
2 min read
BioMidwest

Bond Biosciences Announces Successful Pre-IND Meeting with the FDA to Advance the Development of BBI-001 for Treatment of Iron Overload Associated with Hereditary Hemochromatosis

Bond Biosciences has a clear path for the submission of an IND application to the FDA in the fourth quarter of 2024.

January 11, 2024
·
1 min read
Biotech Bay

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Mainz Biomed N.V. re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024.

January 11, 2024
·
5 min read
Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Avenue Therapeutics, Inc. today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Sidoti January Micro-Cap Investor Conference on Thursday, January 18, 2024 at 10:00 a.m. EST.

January 11, 2024
·
4 min read
Business

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

Halberd Corporation (OTC PINK:HALB) made significant advances in its technology development and accomplished major business goals during the second half of 2023.

January 11, 2024
·
8 min read
Drug Development

Dermavant Announces Positive Data from the ADORING Phase 3 Development Program in Atopic Dermatitis with VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old

Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced new positive efficacy and safety data from analyses of the company’s ADORING Phase 3 development program in atopic dermatitis.

January 11, 2024
·
10 min read